Dyslipidemia in Type 1 Diabetes: A Masked Danger von Verges, Bruno

Volltext

Intestinal lipid absorption and transport in type 2 diabetes von Vergès, Bruno

Volltext

Cardiovascular disease in type 1 diabetes, an underestimated danger: Epidemiological and pathophysiological data von Vergès, Bruno

Volltext

mTOR and Cardiovascular Diseases: Diabetes Mellitus von Vergès, Bruno

Volltext

Do anti-obesity medical treatments have a direct effect on adipose tissue? von Vergès, Bruno

Volltext

Diabetes Induced by Immune Checkpoint Inhibitors (ICIs) von Vergès, Bruno

Volltext

mTOR inhibitors and diabetes von Vergès, Bruno, Cariou, Bertrand

Volltext

Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes von VERGES, Bruno

Volltext

Pathophysiology of diabetic dyslipidaemia: where are we? von Vergès, Bruno

Volltext

Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes. The Lira-NAFLD study von Petit, Jean-Michel, Cercueil, Jean-Pierre, Loffroy, Romaric, Denimal, Damien, Bouillet, Benjamin, Fourmont, Coralie, Chevallier, Olivier, Duvillard, Laurence, Vergès, Bruno

Volltext

Is reduction of hyperglycemia associated with a cardiovascular benefit? von Vergès, Bruno

Volltext

Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms von Verges, Bruno

Volltext

Normal HDL cholesterol efflux and anti-inflammatory capacities in type 2 diabetes despite lipidomic abnormalities von Denimal, Damien, Benanaya, Sara, Monier, Serge, Simoneau, Isabelle, Pais de Barros, Jean-Paul, Le Goff, Wilfried, Bouillet, Benjamin, Vergès, Bruno, Duvillard, Laurence

Volltext

Smoking and diabetes interplay: A comprehensive review and joint statement von Durlach, Vincent, Vergès, Bruno, Al-Salameh, Abdallah, Bahougne, Thibault, Benzerouk, Farid, Berlin, Ivan, Clair, Carole, Mansourati, Jacques, Rouland, Alexia, Thomas, Daniel, Thuillier, Philippe, Tramunt, Blandine, Le Faou, Anne-Laurence

Volltext

Smoking and Diabetes: Sex and Gender Aspects and Their Effect on Vascular Diseases von Tramunt, Blandine, Rouland, Alexia, Durlach, Vincent, Vergès, Bruno, Thomas, Daniel, Berlin, Ivan, Clair, Carole

Volltext

CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice von JOURDAN, Tony, DJAOUTI, Louiza, DEMIZIEUX, Laurent, GRESTI, Joseph, VERGES, Bruno, DEGRACE, Pascal

Volltext

Management of hyperglycemic/diabetic patient during and in the immediate follow-up of an acute coronary syndrome von Vergès, Bruno

Volltext

Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline von Rosenzweig, James L, Bakris, George L, Berglund, Lars F, Hivert, Marie-France, Horton, Edward S, Kalyani, Rita R, Murad, M Hassan, Vergès, Bruno L

Volltext

Liraglutide Increases the Catabolism of Apolipoprotein B100-Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expre... von Verges, Bruno, Duvillard, Laurence, Pais de Barros, Jean Paul, Bouillet, Benjamin, Baillot-Rudoni, Sabine, Rouland, Alexia, Petit, Jean Michel, Degrace, Pascal, Demizieux, Laurent

Volltext

Screening and management of metabolic complications of mTOR inhibitors in real-life settings von Spanjaard, Pamela, Petit, Jean Michel, Schmitt, Antonin, Vergès, Bruno, Bouillet, Benjamin

Volltext